Frost & Sullivan releases the 'Blue Book on the Current State of Digital Treatment for Children with Strabismus and Amblyopia in China'

Frost & Sullivan releases the 'Blue Book on the Current State of Digital Treatment for Children with Strabismus and Amblyopia in China'

Published: 2022/12/20

沙利文发布《中国儿童斜弱视数字治疗现状蓝皮书》

Eyes are the windows to the soul, and it is the wish of every parent to ensure that their children possess healthy eyes. Amblyopia and strabismus, as common diseases in pediatric ophthalmology, are the main causes of visual impairment in children. They not only affect children's normal visual function, causing trouble with daily life and learning, but can even impact future work capabilities. Currently, the treatment of amblyopia and strabismus in children in China mainly relies on traditional methods aimed at improving vision, while treatment for visual function is relatively insufficient. In recent years, with a deeper understanding of amblyopia and strabismus in children and continuous progress in treatment technology, the emergence of new treatment methods represented by digital therapy can effectively make up for the shortcomings of traditional therapy in restoring visual function. At the same time, it can improve treatment compliance, bringing new possibilities to the treatment of amblyopia and strabismus in children.

The 'Blue Book on the Current Status of Digital Therapy for Pediatric Strabismus and Amblyopia in China' (hereinafter referred to as the 'Blue Book') was jointly released by Guangzhou Vision Medical Software Co., Ltd. (hereinafter referred to as 'Vision Medical') and Frost & Sullivan (Frost & Sullivan, hereinafter referred to as 'Frost & Sullivan'). Special thanks are given to Mees Medical for providing research data support for this Blue Book.

This Blue Book is based on relevant guidelines, consensuses, clinical studies on digital therapy for strabismus and amblyopia at home and abroad, as well as the survey results on the current application status of digital therapy in the field of pediatric strabismus and amblyopia treatment in China. It aims to truly reflect the current development status of digital therapy for pediatric strabismus and amblyopia in China, popularize the technical advantages of digital therapy in this field, promote its clinical application, ultimately improve the overall level of children's eye health in China, and enable more children to possess healthy and bright eyes.

《中国儿童斜弱视数字治疗现状蓝皮书》.pdf
download

Download


获取白皮书

沙利文发布《中国儿童斜弱视数字治疗现状蓝皮书》

×
请选择职位类别
请选择
×
联系我们
联系我们
电话

业务咨询热线

(021)54075836

微信
二维码

扫码关注官方微信公众号

返回顶部
返回顶部

联系我们

×
请选择职位类别
请选择
×